Research Article

Risk Factors Affecting the Severity of Full-Term Neonatal Retinal Hemorrhage

Table 1

Descriptive statistics of clinical parameters in full-term newborns.

Total (3054)Group 1 (1202)Group 2 (408)Group 3 (610)Group 4 (184)

Gestational age, mean (min, max)39.3 (38.6, 40)39.3 (38.6, 40)39.3 (38.7, 40.1)39.3 (38.6, 39.7)39.4 (38.7, 40)
Birth weight (g), mean (min, max)3200 (2950, 3480)3220 (2970, 3500)3185 (2930, 3432.5)3090 (2852.5, 3395)3200 (2970, 3400)
Maternal age (years), mean (min, max)28 (25, 31)28 (25, 31)28 (25, 31)27.5 (25, 31)29 (25.8, 32)
Duration of the first stage of labor (h), mean (min, max)5.4 (3.8, 7.8)5.7 (3.8, 8)5.2 (3.8, 7.4)4.8 (3.4, 6.8)4.8 (3.3, 6.6)
Duration of the second stage of labor (h), mean (min, max)0.5 (0.3, 0.8)0.5 (0.3, 0.9)0.4 (0.3, 0.7)0.4 (0.2, 0.7)0.3 (0.2, 0.7)
Biparietal diameter (mm), mean (min, max)94 (91, 96)94 (91, 96)94 (91, 96)94 (92, 95)94 (91, 96)
Amniotic fluid index (mm), mean (min, max)107 (88, 130)106 (86, 130)107.5 (90, 127)109 (89.3, 129.5)108 (92, 134.3)
Anterior superior iliac spine diameter, mean (min, max)24 (24, 25)24 (24, 25)24 (24, 25)24 (24, 25)24 (24, 25)
Iliac spine diameter, mean (min, max)27 (27, 27.5)27 (27, 27.5)27 (27, 27)27 (27, 28)27 (27, 27.1)
Sacral shame diameter, mean (min, max)19 (19, 19)19 (19, 19)19 (18.5, 19)19 (18.5, 19)19 (18.5, 19)
Ischial tuberosity diameter, mean (min, max)8.5 (8, 8.5)8.5 (8, 8.5)8.5 (8, 8.5)8.5 (8, 8.5)8.5 (8, 8.5)
Gender—male, n (%)1636 (53.6)1237 (54.9)212 (52.0)95 (45.2)92 (50.0)
Gender—female, n (%)1418 (46.4)1015 (45.1)196 (48.0)115 (54.8)92 (50.0)
Mode of delivery (SVD), n (%)2117 (69.3)1363 (60.5)377 (92.4)204 (97.1)173 (94.0)
Mode of delivery (CS), n (%)937 (30.7)889 (39.5)31 (7.6)6 (2.9)11 (6.0)
Cesarean history, n (%)432 (14.2)401 (17.8)17 (4.2)7 (3.3)7 (3.8)
Anemia, n (%)126 (4.1)93 (4.1)15 (3.7)6 (2.9)12 (6.5)
Thalassemia, n (%)102 (3.3)75 (3.3)8 (2.0)10 (4.8)9 (4.9)
Pregnancy induced hypertension, n (%)48 (1.6)40 (1.8)3 (0.7)2 (1.0)3 (1.6)
GDM, n (%)217 (7.1)168 (7.5)29 (7.1)11 (5.2)9 (4.9)
Birth canal laceration, n (%)1328 (43.5)836 (37.1)240 (58.8)134 (63.8)118 (64.1)
Preeclampsia, n (%)71 (2.3)57 (2.5)9 (2.2)2 (0.9)3 (1.6)
Eclampsia, n (%)0 (0)0 (0)0 (0)0 (0)0 (0)
Uterine inertia, n (%)206 (6.7)155 (6.9)25 (6.1)17 (8.1)9 (4.9)
Emergency birth, n (%)82 (2.7)53 (2.3)13 (3.2)11 (5.2)5 (2.7)
Polyhydramnios, n (%)18 (0.6)14 (0.6)2 (0.5)1 (0.5)1 (0.5)
Oligohydramnios, n (%)90 (2.9)69 (3.1)12 (2.9)7 (3.3)2 (1.1)
Postpartum hemorrhage, n (%)74 (2.4)56 (2.5)12 (2.9)5 (2.4)1 (0.5)
Premature rupture of membranes, n (%)535 (17.5)411 (18.2)58 (14.2)42 (20.0)24 (13.0)
Placental abruption, n (%)7 (0.2)5 (0.2)2 (0.5)0 (0)0 (0)
Cord around the fetal neck, n (%)866 (28.4)613 (27.2)130 (31.9)64 (30.5)59 (32.1)
Intracranial hemorrhage, n (%)18 (0.6)4 (0.2)10 (2.5)0 (0)4 (2.2)
Cranial hematoma, n (%)3 (0.1)3 (0.1)0 (0)0 (0)0 (0)
NHB, n (%)841 (27.5)604 (26.8)116 (28.4)66 (31.4)55 (29.9)
Maternal ABO blood group incompatibility, n (%)34 (1.1)26 (1.1)4 (1.0)2 (0.9)2 (1.1)
Forceps, n (%)30 (0.1)21 (0.9)5 (1.2)2 (0.9)2 (1.1)
IVF-ET, n (%)25 (0.8)22 (1.0)3 (0.7)0 (0)0 (0)

Group 1 = control; Group 2 = degree I RH; Group 3 = degree II RH; Group 4 = degree III RH.